Story

SpaceX Short Sellers Amass $8.7 Billion in Profits as Stock Drops Below IPO Price, Ortex Reports

ENTHMSVIIDZHZH-TWJAKOHI
Jul 16, 20262 min read
SpaceX Short Sellers Amass $8.7 Billion in Profits as Stock Drops Below IPO Price, Ortex Reports

Summary

Investors betting against SpaceX are sitting on an estimated $8.7 billion in paper profits since the company's IPO, as its share price has fallen below the initial offering level, according to data from Ortex Technologies.

Text size
Background

Short sellers betting against SpaceX have amassed an estimated $8.7 billion in paper profits since the company's initial public offering, according to new data from Ortex Technologies. The gains come as the aerospace and AI firm's stock has fallen below its IPO price, a critical benchmark for newly public companies.

Short Sellers Capitalize on Price Decline

The $8.7 billion figure represents the mark-to-market, or unrealized, profit for investors holding short positions in SpaceX, as reported by the financial analytics firm on Tuesday. This development indicates that a significant volume of bearish bets placed against the company have proven successful in the period following its much-anticipated market debut.

Short selling is a strategy where investors borrow shares to sell them on the open market, aiming to buy them back later at a lower price. The decline of SpaceX's stock below its initial offering price has created this profitable scenario for those short sellers.

Implications for Investor Sentiment

A company's stock trading below its IPO price is often viewed as a negative signal by the market, suggesting that initial valuations may have been too high or that post-IPO performance has not met investor expectations. The breach of this key psychological level can dampen enthusiasm from both retail and institutional investors.

Sample IUX Markets – In-articleAd

The substantial profits for short sellers highlight a strong conviction among some market participants that SpaceX's valuation was unsustainable from the outset. This bearish sentiment now appears to be a significant factor weighing on the stock's performance.

Pressure Mounts on Newly Listed Stock

For SpaceX, the persistent downward pressure presents a challenge. A declining stock price can impact investor confidence, affect employee compensation tied to equity, and potentially make future capital raises more difficult or dilutive for existing shareholders.

While the current gains for short sellers are on paper, they would need to buy back shares to close their positions and realize the profits. This future buying activity, known as short covering, could eventually provide some support for the share price, but the overarching negative sentiment remains a significant headwind.

Read next

More on Stocks
Shenzhen-Listed Jingxin Pharmaceutical Refiles for Hong Kong IPO

Stocks

Shenzhen-Listed Jingxin Pharmaceutical Refiles for Hong Kong IPO

Sep 20, 2026

Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) has resubmitted its application for a main board listing on the Hong Kong Stock Exchange, aiming to secure a dual listing to access international capital. The company specializes in drugs for central nervous system and cardiovascular diseases.

Back to latest news

LATEST